DexCom (DXCM) Misses Q4 EPS by 7c ; Offers Guidance
Get Alerts DXCM Hot Sheet
Price: $80.26 -6.39%
EPS Growth %: +9.8%
Financial Fact:
Interest income: 100K
Today's EPS Names:
FNLC, LSBK, OVLY, More
EPS Growth %: +9.8%
Financial Fact:
Interest income: 100K
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.45, $0.07 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $1.11 billion versus the consensus estimate of $1.1 billion.
GUIDANCE:
DexCom sees FY2025 revenue of ~$4.6 billion, versus the consensus of $4.61 billion.
Non-GAAP Gross Profit Margin of approximately 64% - 65%
Non-GAAP Operating Margin of approximately 21%
Adjusted EBITDA Margin of approximately 30%
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Integra LifeSciences (IART) Tops Q3 EPS by 3c; offers guidance
- Live Oak Bancshares, Inc. (LOB) Misses Q3 EPS by 14c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share